<p>Cells were stained by PE-conjugated monoclonal antibodies against CD137 (clone 4B4-1), or anti-CD137 ligand (clone 4B1-436), (open curves) or their isotype control (MOPC-21), (filled curve).</p
CD137 is a member of the tumor necrosis factor receptor family that is expressed on activated T cell...
The selective expression of CD137 on cells of the immune system (e.g., T and DC cells) and oncogenic...
Stimulation of CD137 ligand on human monocytes has been shown to induce DC differentiation, and thes...
CD137 (also known as 4-1BB) is a surface co-stimulatory glycoprotein originally described as present...
CD137(4-1BB) costimulation and adoptive T cell therapy strongly synergize in terms of achieving maxi...
BACKGROUND: Multiple myeloma (MM) is a malignancy of terminally-differentiated plasma cells, and the...
Multiple myeloma (MM) is a malignancy of terminally-differentiated plasma cells, and the second most...
CD137 (also known as 4-1BB and TNFRSF9) is a member of the tumor necrosis factor receptor superfamil...
<p>(A) Source of cells: Balb/C CD11b<sup>+</sup> cells from bone marrow and spleen and total bone ma...
Abstract: CD137 is a member of the tumor ne-crosis factor receptor family and a potent regula-tor of...
<p>(A) PBMCs from a healthy donor or a CLL patient were stimulated with or without 10 ng/ml PMA and ...
A new monoclonal antibody (mAb) of the IgGl subclass, mAb 104, has been obtained after immunization ...
CD137 is a member of the tumor necrosis factor receptor family that is expressed on activated T cell...
Agonist monoclonal antibodies (mAb) to the immune costimulatory molecule CD137, also known as 4-1BB,...
CD137 (4-1BB) is a surface glycoprotein that belongs to the tumour necrosis factor receptor family (...
CD137 is a member of the tumor necrosis factor receptor family that is expressed on activated T cell...
The selective expression of CD137 on cells of the immune system (e.g., T and DC cells) and oncogenic...
Stimulation of CD137 ligand on human monocytes has been shown to induce DC differentiation, and thes...
CD137 (also known as 4-1BB) is a surface co-stimulatory glycoprotein originally described as present...
CD137(4-1BB) costimulation and adoptive T cell therapy strongly synergize in terms of achieving maxi...
BACKGROUND: Multiple myeloma (MM) is a malignancy of terminally-differentiated plasma cells, and the...
Multiple myeloma (MM) is a malignancy of terminally-differentiated plasma cells, and the second most...
CD137 (also known as 4-1BB and TNFRSF9) is a member of the tumor necrosis factor receptor superfamil...
<p>(A) Source of cells: Balb/C CD11b<sup>+</sup> cells from bone marrow and spleen and total bone ma...
Abstract: CD137 is a member of the tumor ne-crosis factor receptor family and a potent regula-tor of...
<p>(A) PBMCs from a healthy donor or a CLL patient were stimulated with or without 10 ng/ml PMA and ...
A new monoclonal antibody (mAb) of the IgGl subclass, mAb 104, has been obtained after immunization ...
CD137 is a member of the tumor necrosis factor receptor family that is expressed on activated T cell...
Agonist monoclonal antibodies (mAb) to the immune costimulatory molecule CD137, also known as 4-1BB,...
CD137 (4-1BB) is a surface glycoprotein that belongs to the tumour necrosis factor receptor family (...
CD137 is a member of the tumor necrosis factor receptor family that is expressed on activated T cell...
The selective expression of CD137 on cells of the immune system (e.g., T and DC cells) and oncogenic...
Stimulation of CD137 ligand on human monocytes has been shown to induce DC differentiation, and thes...
DOI
Add to ORKG